The Norwegian Medicines Agency reported two more deaths among patients with blood clots at Oslo University Hospital after receiving the AstraZeneca vaccine.
“The Norwegian Medicines Agency can not rule out that these cases may have a connection with the AstraZeneca vaccine,” they wrote in a press release.
According to the news bureau NTB, one of the two people who died was a health worker.
Norway put vaccination with the AstraZeneca vaccine on hold after reports of a rare disease course in some of the people who had received the vaccine. Previously, two people who received the vaccine in Norway had died.
No association has yet been established between the severe cases of blood clots and the vaccine.
“We have been notified of two tragic deaths at Rikshospitalet, among the five patients who have been admitted with the special disease picture,” medical director Steinar Madsen in the Norwegian Medicines Agency told NTB.
Mapping of incidents underway
Madsen did not want to comment on the deaths in detail but confirmed that several of the five who have been admitted to Oslo University Hospital with the rare course of the disease were health workers.
All five were under 55, and three of these are now dead.
“Oslo University Hospital, together with other university hospitals in Norway, has carried out investigations to map these incidents, and this mapping continues,” Madsen added.
The Norwegian Medicines Agency is collaborating with the European Medicines Agency (EMA) to review similar adverse reaction reports in other parts of Europe.
The National Institute of Public Health (FHI) has signaled that a decision would be made on whether the vaccine can be used again in Norway this week.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com